Women’s health market seen reaching $60.99 billion by 2030

By AI, Created 1:12 PM UTC, June 04, 2026, /AGP/ – The Business Research Company says the global women’s health market will grow from $45.36 billion in 2025 to $48.19 billion in 2026, then reach $60.99 billion by 2030. North America leads now, while Asia-Pacific is projected to grow fastest as digital health, early screening and personalized treatments expand.

Why it matters: - The women’s health market is expanding as healthcare systems place more emphasis on conditions that affect women uniquely or disproportionately. - Growth in personalized care, early screening and digital health could broaden access to treatment and preventive care. - The market’s projected rise signals more demand for drugs, diagnostics and services focused on women’s long-term health.

What happened: - The Business Research Company released a women’s health industry report on June 4, 2026. - The report estimates the market will rise from $45.36 billion in 2025 to $48.19 billion in 2026. - The report projects the market will reach $60.99 billion by 2030. - The report puts the market’s 2025-2026 CAGR at 6.2% and the 2026-2030 CAGR at 6.1%. - The report covers women’s health across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - More information is available in the full report and a free sample.

The details: - The report defines women’s health as medical care focused on diagnosing, treating and preventing conditions uniquely or predominantly affecting women. - The scope includes reproductive and menstrual health, pregnancy and childbirth, menopause, breast and ovarian cancer, osteoporosis, cardiovascular disease and autoimmune disorders. - The report says the historical growth has been driven by more chronic health conditions among women, more gynecological care, greater awareness of female-specific diseases, more pharmaceutical research and better access to healthcare facilities. - The forecast growth is tied to higher investment in drugs tailored for women, more demand for personalized treatment plans, broader early screening, wider adoption of digital health tools and more focus on long-term health management. - The report identifies emerging trends including targeted therapies, precision medicine, advanced diagnostics, more non-hormonal treatment options and stronger preventive care. - North America was the largest regional market in 2025 because of established healthcare systems and high awareness. - Asia-Pacific is projected to be the fastest-growing region during the forecast period because of rising healthcare investment, expanding medical infrastructure and growing health awareness among women.

Between the lines: - The report points to a market shift from generalized women’s care toward more tailored and technology-enabled treatment models. - The emphasis on prevention and early screening suggests providers and drug makers may compete more on long-term outcomes, not just acute care. - The regional split suggests mature markets will remain large, but future growth may be concentrated in countries still expanding access and infrastructure.

What’s next: - The market is expected to keep growing as digital health adoption and personalized medicine spread. - The report expects continued investment in women-specific drugs, diagnostics and preventive services through 2030. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables.

The bottom line: - Women’s health is moving from a niche category into a broader growth market, with the strongest upside tied to prevention, personalization and digital tools.